DE602005012365D1 - Verfahren zur synthese von n-ä3-(3-cyanopyrazoloä1,5aüpyrimidin-7-yl)-phenylü-n-ethylacetamid - Google Patents

Verfahren zur synthese von n-ä3-(3-cyanopyrazoloä1,5aüpyrimidin-7-yl)-phenylü-n-ethylacetamid

Info

Publication number
DE602005012365D1
DE602005012365D1 DE602005012365T DE602005012365T DE602005012365D1 DE 602005012365 D1 DE602005012365 D1 DE 602005012365D1 DE 602005012365 T DE602005012365 T DE 602005012365T DE 602005012365 T DE602005012365 T DE 602005012365T DE 602005012365 D1 DE602005012365 D1 DE 602005012365D1
Authority
DE
Germany
Prior art keywords
ethylacetamide
phenylü
synthesis
propenyl
dimethylamino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE602005012365T
Other languages
English (en)
Inventor
Laszlo Czibula
Laszlo Dobay
Katalin Szoeke
Papp Eva Werkne
Bagdy Judit Nagyne
Gabor Tarkanyi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richter Gedeon Nyrt
Original Assignee
Richter Gedeon Nyrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Nyrt filed Critical Richter Gedeon Nyrt
Publication of DE602005012365D1 publication Critical patent/DE602005012365D1/de
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/34Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/42Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C07C233/43Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Anesthesiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DE602005012365T 2004-02-02 2005-01-31 Verfahren zur synthese von n-ä3-(3-cyanopyrazoloä1,5aüpyrimidin-7-yl)-phenylü-n-ethylacetamid Expired - Fee Related DE602005012365D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0400325A HUP0400325A3 (en) 2004-02-02 2004-02-02 Pure n-[3-(-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-n-ethyl-acetamide, process for its preparation and intermediates
PCT/HU2005/000008 WO2005073235A2 (en) 2004-02-02 2005-01-31 Process for the synthesis of n- [3-(3-cyanopyrazolo [1,5a] pyrimidin-7-yl)-phenyl]-n-ethyl-acetamide

Publications (1)

Publication Number Publication Date
DE602005012365D1 true DE602005012365D1 (de) 2009-03-05

Family

ID=89981959

Family Applications (2)

Application Number Title Priority Date Filing Date
DE602005012365T Expired - Fee Related DE602005012365D1 (de) 2004-02-02 2005-01-31 Verfahren zur synthese von n-ä3-(3-cyanopyrazoloä1,5aüpyrimidin-7-yl)-phenylü-n-ethylacetamid
DE602005015902T Expired - Fee Related DE602005015902D1 (de) 2004-02-02 2005-01-31 N-ä3- Ä3-(dimethylamino)-1-oxo-2-propenylÜphenylü-N-ethyl-acetamide hydrochlorid

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE602005015902T Expired - Fee Related DE602005015902D1 (de) 2004-02-02 2005-01-31 N-ä3- Ä3-(dimethylamino)-1-oxo-2-propenylÜphenylü-N-ethyl-acetamide hydrochlorid

Country Status (9)

Country Link
EP (2) EP1950213B1 (de)
JP (1) JP2007519700A (de)
AT (2) ATE420882T1 (de)
DE (2) DE602005012365D1 (de)
EA (1) EA010830B1 (de)
HU (1) HUP0400325A3 (de)
NO (1) NO20063917L (de)
RS (1) RS20060427A (de)
WO (1) WO2005073235A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005099712A2 (en) * 2004-04-19 2005-10-27 Sanmar Speciality Chemicals Limited Process for preparation of n-[3-(3-cyanopyrazolo [1,5-a]pyrimidin-7-yl)phenyl]-n-ethylacetamide
WO2006070244A2 (en) * 2004-11-22 2006-07-06 Bakulesh Mafatlal Khamar A process for the preparation of zaleplon

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4626538A (en) 1983-06-23 1986-12-02 American Cyanamid Company [7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidines
US5714607A (en) * 1995-12-01 1998-02-03 American Cyanamid Company Process improvement in the synthesis of N- 3-(3-cyano-pyrazolo 1,5-a!pyrimidin-7-yl)phenyl!-N-ethylacetamide
TR200402588T3 (tr) * 2001-06-12 2004-11-22 Biogal Gyogyszergyar Rt N-[3-(3-siyanopirazolo[1,5-A]pirimidin-7-il)fenil]-N- etilasetamidin(zaleplon) üretim işlemi
WO2003011228A2 (en) * 2001-08-01 2003-02-13 Biogal Gyogyszergyar Rt Purification and crystalline forms of zaleplon
PL207322B1 (pl) * 2002-05-14 2010-11-30 Adamed Społka Z Ograniczoną Odpowiedzialnością Sposób wytwarzania zaleplonu

Also Published As

Publication number Publication date
HU0400325D0 (en) 2004-04-28
EP1711501B1 (de) 2009-01-14
EP1950213B1 (de) 2009-08-05
RS20060427A (en) 2008-08-07
JP2007519700A (ja) 2007-07-19
HUP0400325A2 (hu) 2005-09-28
EP1950213A2 (de) 2008-07-30
HUP0400325A3 (en) 2005-11-28
EP1711501A2 (de) 2006-10-18
EP1950213A3 (de) 2008-08-13
WO2005073235A2 (en) 2005-08-11
EA010830B1 (ru) 2008-12-30
NO20063917L (no) 2006-11-01
DE602005015902D1 (de) 2009-09-17
ATE420882T1 (de) 2009-01-15
EA200601417A1 (ru) 2006-12-29
WO2005073235A3 (en) 2005-10-06
ATE438647T1 (de) 2009-08-15

Similar Documents

Publication Publication Date Title
DE602005016603D1 (de) Kristalline formen von (r)-8-chlor-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepinhydrochlorid
ATE445587T1 (de) Verfahren zur herstellung von cinacalcet hydrochlorid kristallform i
DE60330357D1 (de) Verfahren zur herstellung von 3-halogen-4,5-dihydro-1 h-pyrazolen
DE602004004663D1 (de) Verfahren zur herstellung von 2- (chinoxalin-5-ylsulfonylamino) -benzamid-verbindungen
MX2007004637A (es) Sintesis asimetrica de derivados de dihidrobenzofurano.
BR0213931A (pt) Forma polimórfica de rimonabant, processo para sua preparação e composições farmacêuticas contendo-as
ATE452882T1 (de) Herstellung von quetiapin
HK1078315A1 (en) Synthesis of 2-hydroxy-n,n-dimethyl-3- 2- 1(r)-(5-methyl-2-furanyl)propyl amino -3,4-dioxo-1-cyclobuten- 1-yl amino benzamide
ATE398121T1 (de) Neue synthese von irbesartan
DE602005012365D1 (de) Verfahren zur synthese von n-ä3-(3-cyanopyrazoloä1,5aüpyrimidin-7-yl)-phenylü-n-ethylacetamid
DK1599460T3 (da) Oxathiincarboxamider
DE602007012725D1 (de) Verfahren zur Herstellung von N-(Diphenylmethyl)piperazinen
ATE325794T1 (de) Verfahren zur herstellung und zwischenprodukte von pyridin-2-yl-amin
DE602004031129D1 (de) Verfahren zur herstellung von quetiapin
DE602005022213D1 (de) Verfahren zur herstellung von phenyl-2-pyrimidinyl-ketonen und neuen zwischenprodukten daraus
DE60306361D1 (de) Verfahren zur herstellung von benazeprilhydrochloride
DE602004010530D1 (de) Verfahren zur herstellung von phenyltetrazolderivaten
ATE387423T1 (de) Verfahren zur herstellung der enantiomeren formen von 2,3-diaminopropionsäurederivaten
DE602006006334D1 (de) Verfahren zur herstellung von aminosäurederivaten
DE50312447D1 (de) Verfahren zur herstellung von 4,6-dichlor-5-fluorpyrimidin
ATE516278T1 (de) Verfahren zur herstellung von amidverbindungen

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee